Acinetobacter baumannii: An Emerging and Important Pathogen
- PMID: 26966345
- PMCID: PMC4782967
Acinetobacter baumannii: An Emerging and Important Pathogen
Abstract
Objective: To review the clinical significance, management, and control of Acinetobacter infections.
Methods: Literature review.
Results: Acinetobacter infections have become a major cause of hospital-acquired infections worldwide. Acinetobacter is noted for its ability to survive for long periods on hospital surfaces and equipment, its predilection to develop resistance to multiple antibiotics, its affinity to cause serious infections in critically ill patients, and many well described outbreaks attributable to contamination of a common source. The crude ICU mortality is approximately 40%. Rigorous antibiotic stewardship and infection control measures are critical to prevent the spread of multidrug-resistant Acinetobacter infections. There is also a pressing need for new therapeutic options.
Conclusion: Acinetobacter is an emerging pathogen of increasing significance.
Figures
References
-
- Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. In: Murray PR, Baron EJ, Jorgensen JA, et al., editors. Manual of clinical microbiology. 8th ed. American Society Microbiology; Washington DC: 2003. pp. 749–79.
-
- Fournier PY, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infec Dis. 2006;42:692–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources